Chronic Hepatitis C Virus
Reports from H. Orlent et al highlight recent research in chronic hepatitis C virus
Published in Hepatitis Weekly, January 10th, 2011
"To validate a stopping rule based on baseline anti-NS4a antibody levels and early on-treatment virological response in treatment-naive genotype 1 chronic hepatitis C patients treated with the current standard pegylated interferon and ribavirin combination therapy. Eighty-nine genotype 1...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2011-01-10)
More Articles from Hepatitis Weekly
- Hepatitis
Data from X.H. Tian et al provide new insights into hepatitis - Chronic Hepatitis C Virus
Investigators at Nottingham University, Digestive Diseases Center zero in on chronic hepatitis C virus - Hepatitis C Virus
New findings from University of Toronto, Institute of Medical Science in the area of hepatitis C virus described - Hepatitis C Virus
New hepatitis C virus study findings recently were published by researchers at Kaohsiung Medical University - Hepatocellular Cancer
Research conducted at Y. Zhou and co-authors has provided new information about hepatocellular cancer - Hepatitis B Virus
Research findings from Johns Hopkins University update understanding of hepatitis B virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
